These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10497116)

  • 1. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.
    Dunster LM; Wang H; Ryman KD; Miller BR; Watowich SJ; Minor PD; Barrett AD
    Virology; 1999 Sep; 261(2):309-18. PubMed ID: 10497116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of wild-type yellow fever virus by passage in HeLa cells.
    Barrett AD; Monath TP; Cropp CB; Adkins JA; Ledger TN; Gould EA; Schlesinger JJ; Kinney RM; Trent DW
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2301-6. PubMed ID: 2230735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.
    Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD
    Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it.
    Jennings AD; Whitby JE; Minor PD; Barrett AD
    Virology; 1993 Feb; 192(2):692-5. PubMed ID: 8421909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex.
    Davis EH; Beck AS; Strother AE; Thompson JK; Widen SG; Higgs S; Wood TG; Barrett ADT
    mBio; 2019 Oct; 10(5):. PubMed ID: 31641088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.
    Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD
    Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus.
    Sil BK; Dunster LM; Ledger TN; Wills MR; Minor PD; Barrett AD
    J Virol; 1992 Jul; 66(7):4265-70. PubMed ID: 1376368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine.
    Wang E; Ryman KD; Jennings AD; Wood DJ; Taffs F; Minor PD; Sanders PG; Barrett AD
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2749-55. PubMed ID: 7595382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus.
    McArthur MA; Xiao SY; Barrett AD
    Virus Res; 2005 Jun; 110(1-2):65-71. PubMed ID: 15845256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological characterization of plaque-size variants of yellow fever virus in mosquitoes and mice.
    Miller BR; Adkins D
    Acta Virol; 1988 May; 32(3):227-34. PubMed ID: 2902770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection.
    Lefeuvre A; Contamin H; Decelle T; Fournier C; Lang J; Deubel V; Marianneau P
    Microbes Infect; 2006 May; 8(6):1530-8. PubMed ID: 16697681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.
    Engel AR; Vasconcelos PF; McArthur MA; Barrett AD
    Vaccine; 2006 Apr; 24(15):2803-9. PubMed ID: 16464518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of neurovirulence of different strains of yellow fever virus in mice.
    Barrett AD; Gould EA
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():631-7. PubMed ID: 3958694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression.
    Khaiboullina SF; Rizvanov AA; Holbrook MR; St Jeor S
    Virology; 2005 Nov; 342(2):167-76. PubMed ID: 16150475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Diversity Does Not Contribute to Attenuation of HeLa Passaged Wild-Type Yellow Fever Virus Strain French Viscerotropic Virus.
    Strother AE; Thompson JK; Widen SG; Barrett ADT
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein.
    Bonaldo MC; Garratt RC; Freire MS; Galler R
    Cell Biochem Biophys; 2006; 44(3):313-24. PubMed ID: 16679518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools.
    Gould EA; Buckley A; Cane PA; Higgs S; Cammack N
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1889-94. PubMed ID: 2472467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
    Barrett AD; Mathews JH; Miller BR; Medlen AR; Ledger TN; Roehrig JT
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.